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A B S T R A C T
The breach of proteostasis, leading to the accumulation of protein aggregates, is a hallmark of ageing and age-
associated disorders, up to now well-established in neurodegeneration. Few studies have addressed the issue of
dysfunctional cell response to protein deposition also for the cardiovascular system. However, the molecular
basis of proteostasis decline in vascular cells, as well as its relation to ageing, are not understood. Recent studies
have indicated the associations of Nrf2 transcription factor, the critical modulator of cellular stress-response,
with ageing and premature senescence. In this report, we outline the significance of protein aggregation in
physiological and premature ageing of murine and human endothelial cells (ECs). Our study shows that aged
donor-derived and prematurely senescent Nrf2-deficient primary human ECs, but not those overexpressing
dominant-negative Nrf2, exhibit increased accumulation of protein aggregates. Such phenotype is also found in
the aortas of aged mice and young Nrf2 tKO mice. Ageing-related loss of proteostasis in ECs depends on Keap1,
well-known repressor of Nrf2, recently perceived as a key independent regulator of EC function and protein S-
nitrosation (SNO). Deposition of protein aggregates in ECs is associated with impaired autophagy. It can be
counteracted by Keap1 depletion, S-nitrosothiol reductant or rapamycin treatment. Our results show that
Keap1:Nrf2 protein balance and Keap1-dependent SNO predominate Nrf2 transcriptional activity-driven me-
chanisms in governing proteostasis in ageing ECs.
1. Introduction
Loss of protein homeostasis (proteostasis) is a hallmark of ageing.
The gradual accumulation of misfolded and aggregated proteins im-
pairs intracellular processes and cell function, contributing to multiple
age-related diseases [1–3]. It also correlates with the functional decline
and lifespan reduction in many species, including yeast, nematodes,
insects and mammals [4]. Accordingly, the proteomes of long-lived
eukaryotic organisms are less prone to aggregate [4,5], and modulation
of proteostasis components affects invertebrate and vertebrate health
and lifespan [1,6].
The detrimental effect of protein aggregation is best established for
neurological disorders [7]. Besides, we start to recognise its role in
cardiac disease [8,9]. However, abnormal protein deposition may also
cause endothelial cell (EC) dysfunction [10], and the impairment of
cellular response to aggregating proteins occurs in atherosclerosis [11]
and diabetes [12]. Therefore the cardiovascular system seems to be the
second, next to the nervous system, strongly influenced by proteostasis-
related pathomechanisms. Still, it has not been elucidated if age favours
the formation of protein aggregates in ECs and the molecular me-
chanisms of proteostasis loss in the vascular system remain uncovered.
Nrf2 (nuclear factor erythroid 2-related factor 2), encoded by the
NFE2L2 gene, is a transcription factor controlling homeostatic response
to cellular anomalies, including oxidative stress. It has received much
attention as one of the significant determinants of ageing [13,14].
Transcriptional modulation of the cellular processes, such as premature
senescence, mitochondrial dysfunction, or impaired unfolded protein
response, is considered to explain the Nrf2 associations with ageing
[15]. Here, we describe another mechanism, which prevails Nrf2
transcriptional activity.
We demonstrate that physiological and premature ageing promotes
protein aggregation in murine and human ECs. We show that the
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accumulation of protein aggregates results from autophagy impairment
and is accompanied by a deregulated proteostasis network. Deposition
of aggregates relies on protein S-nitrosation driven by Keap1, the thiol-
rich redox-sensitive protein, broadly recognised as the repressor of Nrf2
transcriptional activity, recently identified as a critical Nrf2-in-
dependent player in EC function [16,17]. Loss of proteostasis in ECs can
be prevented either by pharmacological induction of autophagy by
rapamycin, or Keap1 depletion or treatment of cells with ascorbate, an
Fig. 1. Physiological ageing and premature senescence favour protein aggregation in the human and murine aortic endothelium. (A–B) Assessment of the
level of protein aggregates in HAECs isolated from young and aged donors. Age and sex of donors are pointed out. Protein aggregates were detected using a
fluorescent probe. (A) Representative images of 9 experiments. Scale bar 5 μm. (B) Quantitative analysis by flow cytometry. Student's t-test, n = 9, ***p < 0.001.
(C–D) Analysis of protein aggregates in Nrf2-deficient HAECs derived from a young donor. Protein aggregates were detected using a fluorescent probe. The cells were
incubated for 24 h with 5 μM MG132, which was used here as a positive control. (C) Representative images of 5 experiments. Scale bar 10 μm. (D) Quantitative
analysis of protein aggregates by flow cytometry. Two-way ANOVA+ Tukey's post-hoc test, n = 4, ***p < 0.001. (E–F) Assessment of level of protein aggregates in
the abdominal aorta of young and aged WT and Nrf2 tKO mice. Protein aggregates were detected using a fluorescent probe. (E) Representative images of 8 animals.
Scale bar 10 μm. (F) Scoring of protein aggregation. Two-way ANOVA + Tukey's post-hoc test, n = 8, ***p < 0.001.




Physiological ageing and premature senescence favour protein
aggregation in the human and murine aortic endothelium. To verify if
ageing impacts proteostasis in ECs, we inspected the formation of
protein aggregates in primary human aortic endothelial cells (HAECs)
isolated from donors of different age. A substantial increase in protein
aggregation was found in aged HAECs in comparison to young donor-
derived cells (Fig. 1A and B). The aggregates were observed in less than
10% and ~95% of young and aged donor-derived cells, respectively.
Whereas the accumulation of aggregates was minor in the case of cells
isolated from a 62-year-old donor, the octogenarian-derived HAECs
displayed a robust incidence of protein aggregation (Fig. 1A and B). We
also observed the enhanced formation of aggregates in young donor-
derived HAECs devoid of Nrf2 (siNFE2L2) (Fig. 1C, D, S1A), which
exhibit premature senescence [16]. The level of protein aggregate de-
position was comparable between Nrf2-deficient and proteasome in-
hibitor MG132-treated HAECs (Fig. 1C and D). Aggregation of proteins
was found in the vast majority of siNFE2L2 (90–95%) and very few
siMock cells. In contrast, no protein aggregates were observed in young
donor-derived HAECs overexpressing dominant-negative Nrf2 (Fig.
S1B), which also do not undergo premature senescence [17]. En face
staining of aggregates in the aortas of young (8-week old) and aged (12-
14-month old) wild-type, and Nrf2 transcriptional knockout (tKO) mice
revealed an appreciable increase in their accumulation in aged animals,
stronger in Nrf2 tKO mice compared to WT (Fig. 1E, F, S1C). The ag-
gregates were the most abundantly present in the aortic arch and ab-
dominal part of the aorta, but not in the thoracic part. A similar phe-
notype was also observed in the aortas of young Nrf2 tKO mice (Fig. 1E,
F, S1C), which are prematurely senescent [17]. These data demonstrate
that both physiological and Nrf2-related premature ageing of human
and murine ECs is associated with protein aggregation. Moreover, the
phenotype of proteostasis loss is accompanied by the functional an-
giogenic and proliferative impairment of aged and senescent HAECs
(Fig. S1D and E and [16]).
Globular protein aggregates predominate in ECs. The fibrillar form
of protein aggregation is the prevailing one in neurodegenerative dis-
eases [18]. In contrast, fluorescent staining of protein aggregates in
aged and senescent Nrf2-deficient HAECs showed mainly globular form
of aggregates spread throughout the cytoplasm (Fig. 2A and B). Imaging
of siMock and siNFE2L2 cells with atomic force microscopy (AFM)
confirmed the presence of stiff structures in the cytoplasm of Nrf2-de-
ficient, but not in control cells (Fig. 2C). These structures appeared as
globules of 2.23 ± 0.19 μm in diameter (Fig. 2D), localised beneath
the actin fibres (Fig. 2E), which may reflect larger protein aggregates or
clusters of protein aggregates visualised by the fluorescent probe
(Figs. 1C and 2B). The AFM profiling of the globule surface (Fig. 2F and
G) indicated that their height is 0.36 ± 0.01 μm.
Nrf2 deficiency impairs basal and starvation-induced autophagy
in ECs. Mass spectrometry proteome analysis of the soluble fraction of
proteins from Mock and NFE2L2 RNAi-transfected young donor-derived
HAECs [16] revealed substantial deregulation among the mediators of
protein homeostasis (Fig. 3A). The differences between siMock and
siNFE2L2 proteome profiles were observed in case of proteins building
up ribosomes, involved in translation, protein folding and degradation
via proteasome (Fig. 3B–E), which could account for the increased
number of aggregates seen in Nrf2-deficient cells. Since the clearance of
protein aggregates, irrespective of their origin, occurs mainly through
autophagy [19,20], we hypothesised that enhanced aggregation of
proteins in Nrf2-deficient cells results from the autophagy impairment.
Real-time cell imaging revealed that the depletion of Nrf2 hampers the
starvation-induced formation of autolysosomes. Moreover, Nrf2-defi-
cient HAECs displayed fewer but bigger autophagosomes (LC3-GFP) at
the basal state, which might be caused by their clustering (Fig. 4A and
B). The level of crucial autophagy regulators, Atg3, Atg7, Atg12 and
p62 (Fig. 4C, D, S2A, B), but not Atg5 and Atg16L (Fig. 4C, S2A), were
significantly diminished in basal conditions and/or upon 3 h starvation
in siNFE2L2 HAECs in comparison to Mock-transfected cells. These re-
sults show that the proteostasis network and the process of starvation-
induced autophagy are impaired in HAECs devoid of Nrf2. Moreover,
the deposition of protein aggregates in siNFE2L2 cells triggers no au-
tophagy flux.
Rapamycin reverses the senescent phenotype of Nrf2-deficient ECs
through the induction of autophagy and protein aggregate clearance.
To further elucidate the autophagy status in Nrf2-deficient cells, we
incubated them with rapamycin, the mTOR inhibitor and autophagy
inducer [21]. Stimulation of cells with a non-toxic concentration of
rapamycin induced autolysosome formation regardless of the Nrf2 level
within 1 h (Fig. 5A and B). Rapamycin diminished the level of protein
aggregates in HAECs lacking Nrf2 to control degree (Fig. 5C and D).
Moreover, it reversed the senescent phenotype of siNFE2L2 cells as-
sessed by the measurement of senescence-associated β-galactosidase
(SA-β-gal) activity (Fig. 5E), further confirmed by decreased p21 and
p53 protein levels (Fig. 5F, S3A) and restored the cell proliferation
(Fig. 5G). To verify if rapamycin exerted its positive effect through
autophagy induction, ATG7, a crucial regulator of autophagy [22], was
knocked down in siNFE2L2 HAECs (Fig. S1A). Atg7 depletion abolished
the positive effects of rapamycin, as verified by the percentage of
PCNA-positive cells (Fig. 5H). Rapamycin also had a positive impact on
proteostasis in aged-donor derived HAECs decreasing the number of
aggregates (Fig. 6A and B) and enhancing their proliferation potential
(Fig. 6C). Similar results were obtained in the in vivo study, where
treatment of animals with rapamycin induced aggregate clearance in
the aorta of Nrf2 tKO and ageing animals (Fig. 6D and E). These data
show the interdependence of impaired autophagy, protein aggregation
and ageing or senescent phenotype of ECs.
Age- and senescence-related protein aggregation and autophagy
impairment depend on Keap1. Recently we have found that dysfunc-
tion of ECs devoid of Nrf2 results from the overabundance of Keap1,
and is independent of Nrf2 transcriptional activity. Keap1, unrestrained
by Nrf2, induces massive protein S-nitrosation (SNO), prevents podo-
some assembly and angiogenesis, and triggers premature senescence in
ECs [16,17]. In the present study, Keap1 level was much higher in Nrf2-
deficient HAECs comparing to control cells, which corroborates our
previous data [16,17]. We noticed that it was distributed partly in foci
and partly evenly in the cytoplasm (Fig. 7A). The globular protein ag-
gregates were observed to colocalise with Keap1 in siNFE2L2 cells
(Pearson's r = 0.874) (Fig. 7A), which may indicate the crucial role of
Keap1 in the formation or maintenance of those structures. Mass
spectrometry analysis of an aggregating fraction of proteins in siNFE2L2
young donor-derived HAECs compared to siMock control revealed that
more than 60% of them are involved in translation and protein folding
and also build up ribosomes (Fig. 7B, Table 1). Interestingly, all of them
either contain the ETGE-like motif and/or increased content of amino
acids promoting intrinsic disorder propensity [23] (Table 1), which
may facilitate their binding to Keap1 [24–26]. Of note, simultaneous
silencing of KEAP1 in siNFE2L2 HAECs (Fig. 7C, S4A) abrogated protein
aggregation (Fig. 7D, S4B), restored p62 level (Figs. S5A and B), star-
vation-induced Atg12 and Atg7 levels (Figs. S5C and D), and functional
autophagy (Figs. S5E and F). Moreover, protein aggregation was in-
creased upon adenoviral-mediated overexpression of Keap1 in Nrf2-
deficient ECs. Such effect, though to the lower extent, was also visible
in Keap1 overexpressing Mock-transfected cells (Fig. S6A). In ac-
cordance, the level of Keap1 was significantly reduced in rapamycin-
treated cells, which showed the increased conversion of LC3B (Fig. 7E,
S6B) and aggregate clearance (5C, D). Analysis of Keap1 and Nrf2 level
in young and aged-donor derived HAECs revealed that Keap1/Nrf2
ratio robustly elevates with age (Fig. 7F, S7A). It may suggest the in-
sufficient saturation of Keap1 by Nrf2 in aged ECs. Depletion of Keap1
reverted protein aggregation, increased proliferation potential and the
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Fig. 2. Globular protein aggregates predominate in ECs. (A–B) High-resolution images of protein aggregates in (A) HAECs isolated from young and aged donors,
(B) Nrf2-deficient young donor-derived HAECs. Representative images of 3 experiments. Green - actin, red - aggregates, blue - nuclei. Scale bar 2 μm. (C–G) Analysis
of cellular topography and stiffness of siMock and siNFE2L2 young donor-derived HAECs using atomic force microscopy. (C) Representative images of cellular
topography. n = 3, black scale bar 5 μm, white scale bar 1 μm. (D) Measurement of the diameter of globule cytoplasmatic structures visualised in siNFE2L2 young
donor-derived HAECs. n = 45. (E) Stiffness map of the globular objects visualised in siNFE2L2 young donor-derived HAECs, obtained before and after the treatment
with cytochalasin. Representative images. n = 3, scale bar 1 μm. (F–G) The AFM profiling of the globule surface. (F) Assessment of the height of the globule
structures visualised in siNFE2L2 young donor-derived HAECs. n = 45. (G) Exemplary profile of the globule structures. (For interpretation of the references to colour
in this figure legend, the reader is referred to the Web version of this article.)
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angiogenic response of aged-donor derived HAECs (Fig. 7G–I, S7B).
These data show that the loss of proteostasis in physiologically and
prematurely ageing ECs depends on Keap1.
Protein aggregation is dependent on Keap1-driven S-nitrosation.
Recently we found that Keap1 controls SNO and together with NO
synthase and GAPDH forms a mammalian enzymatic complex necessary
for this modification [17]. Moreover, SNO is known to interfere with
the proteostasis network in cells, inhibit autophagy and promote pro-
tein aggregation [27,28]. Interestingly, in Nrf2-deficient ECs, we ob-
served that globular protein aggregates colocalise with S-nitrosated
proteins (Pearson's r = 0.821) (Fig. 8A). Treatment of siNFE2L2 cells
with sodium ascorbate (SA, 1 mM, 24 h), the S-nitrosothiol reductant
[29], eliminated protein aggregates. Moreover, it reduced the level of
Keap1 in Nrf2-deficient ECs (Fig. 8B, S8A). It suggests that protein
aggregation may depend on Keap1-related protein S-nitrosation in
siNFE2L2 ECs. To further corroborate those findings in physiological
ageing, we incubated old-donor derived HAECs with SA. In accordance
with premature senescence model, we observed a decrease in protein
aggregates and Keap1 level in response to SA treatment (Fig. 8C, S8B).
Overall, these results imply that the mechanism of protein aggregation
in Nrf2-deficient and physiologically ageing cells might be related to
Keap1-dependent S-nitrosation. Both, aggregation of SNO-modified
proteins as well as regulation of proteostatic machinery by SNO can be
considered as the potential molecular basis of Keap1-dependent protein
aggregation.
3. Discussion
Loss of proteostasis is one of the characteristics of ageing cells. The
decline in chaperone availability and activity, and dysfunction of pro-
teolytic systems, leading together to the accumulation of protein ag-
gregates, are the primary cellular mechanisms determining the pro-
teostatic imbalance in ageing [1,30]. Such relation is well-established
mostly in age-related neurological disorders [31]. Apart from neurons,
age-related deposition of protein inclusions was also shown in the heart
[9] and muscle fibres [32]. It remains elusive, however, how ageing
affects proteostasis in the vascular system, particularly in ECs, and how
it influences the function of blood vessels. It has been found that the
abnormal response to unfolded proteins may have an impact on the
pathogenesis of atherosclerosis [11] and diabetes [33–35], both directly
related to endothelial dysfunction. Taking into account that the cardi-
ovascular system is dramatically affected by ageing, potential dys-
function of proteostatic mechanisms in aged vascular cells is likely.
The striking correlation between Nrf2 and lifespan observed in
mammals, flies and nematodes [14] gives a great incentive to elucidate
its molecular basis. The substantial decrease in transactivation of Nrf2
target genes is pointed out as the leading cause of ageing and impair-
ment of cellular function [36]. The role of Nrf2 in the context of pro-
teostasis is mostly attributed to transcriptional regulation of genes be-
longing to the ubiquitin-proteasome system and autophagy [15,37–40].
Moreover, modulation of unfolded protein response by Nrf2 through
the effect on reactive oxygen species has also been proposed [15]. Our
findings indicate that both physiological and premature Nrf2-related
ageing favours the accumulation of protein aggregates in ECs and
highlight the primary role of Keap1 in this process. Remarkably, this
role is not related to the Keap1-dependent regulation of Nrf2 activity.
We observed that Keap1 colocalises with globular protein ag-
gregates in aged and Nrf2-deficient young donor-derived HAECs.
Notably, Keap1 was shown to colocalise with ubiquitin-positive ag-
gregates in HEK293 cells [41], p62-positive inclusions in autophagy-
defective hepatocytes [42], and with p62-positive LC3-negative ag-
gregates in muscle biopsies from human autophagic vacuolar myopathy
(AVM) [43]. The functional meaning of Keap1/aggregate colocalisation
might be, however, bimodal. In basal conditions in cells with the
normal level of Nrf2, Keap1 assists in ubiquitin aggregate clearance
through autophagy, where it interacts with p62 and LC3. Thus, in this
case, the depletion of Keap1 leads to autophagy impairment and in-
creased deposition of protein aggregates [41]. In the setting of autop-
hagy disorder, like in AVM induced by hydroxychloroquine or colchi-
cine (autophagy inhibiting drugs used for rheumatologic disorders and
gout), Keap1 is sequestered by p62-positive protein aggregates, which
triggers Nrf2 release and its hyperactivation [43]. A similar mechanism
was found in the autophagy-defective livers [42]. In the case of aged
ECs and young donor-derived Nrf2-deficient ECs, which both are
characterised by a substantial deposition of protein aggregates, the
ratio of cytoplasmic Keap1 and Nrf2 is heavily imbalanced too.
Therefore we postulate that in ageing cells and cells with defective
autophagy, Keap1 is not saturated by Nrf2, does not undergo de-
gradation and can serve as a cytoplasmic protein hub, sequestering
proteins and inducing their accumulation. As our data show, this pro-
cess can be counteracted by either Keap1 depletion or autophagy in-
duction by rapamycin. Under this view, in the cataractous lens, which is
an age-related disorder caused by excessive protein aggregation [44],
Keap1 level increases [45].
Keap1 is a protein possessing a broad interactome [46]. Its binding
partners contain sequences resembling the ETGE motif, less often DLG
motif, which are responsible for their direct interaction with Keap1
[25,46]. Moreover, the Kelch domain of Keap1 preferentially binds
intrinsically disordered proteins (IDPs) [25]. Therefore, we suppose
that the process of protein sequestration by free Keap1 in the cytoplasm
might be related to its high affinity to IDPs [25,26]. Of note, almost all
proteins identified in aggregates in Nrf2-deficient cells contain an in-
creased number of intrinsic disorder-promoting amino acid residues
[23]. Many of them possess motifs resembling ETGE. Although the
conserved segment for interactions with the Kelch domain of Keap1 is
GE, usually EXGE, and it is valid for majority of verified Keap1 partners
[47], the direct interactions of Keap1 dependent on ELKE and ENKE
motifs were shown too [48]. Binding of IDPs may be the mechanism of
protein sequestration by Keap1 in Nrf2-deficient ECs and possibly fur-
ther aggregation.
Intriguingly, the globular aggregates, which colocalise with Keap1
in Nrf2-deficient ECs, seem to consist of SNO-modified proteins. A de-
crease in protein aggregates in response to SA treatment in siNFE2L2
and aged-donor derived cells suggests that ageing-related protein ag-
gregation may depend on SNO, and possibly it represents a mechanism
on how Keap1 triggers protein aggregation. Since the incubation of cells
with SA was done 48 h after siRNA transfection, we may conclude that
SA induced the clearance of protein aggregates in siNFE2L2 cells.
Ascorbate was suggested to induce autophagy in cancer cells [49,50] by
the mechanism which was not recognised. In view of our results, we
may propose that Keap1-dependent S-nitrosation blocks the process of
autophagy, thus facilitating protein aggregation. Depletion of S-ni-
trosation by SA or Keap1 knockdown rescue the ability of cells to in-
duce autophagy-dependent clearance of protein aggregates.
The critical question raised by this study is whether the pre-
dominant mechanism of ageing-associated impairment of autophagy-
dependent on Keap1 is related to its repressive influence on Nrf2 (and
thus Nrf2 transcriptional activity) or other, Nrf2-independent, Keap1
functions. The studies have convincingly shown that p62, ubiquitin and
Trim16, modulating autophagy, are regulated by Nrf2 on the
Fig. 3. Mass spectrometry profiling of control and Nrf2-deficient ECs. (A) Functional classification of proteins with a significantly (p < 0.05) altered level in
siNFE2L2 young donor-derived HAECs in comparison to Mock-transfected cells. A soluble-fraction of proteins was analysed by mass spectrometry. FC – fold change.
n = 5, Mann-Whitney U test. (B-E) Proteostasis-related proteins with a significantly different level in siNFE2L2 young donor-derived HAECs in comparison to Mock-
transfected cells. Whole-cell lysates were analysed by mass spectrometry. FC – fold change. n = 5, Mann-Whitney U test.
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Fig. 4. Nrf2 deficiency impairs starvation-induced autophagy in ECs. (A–B) Monitoring of formation of autolysosomes in siMock and siNFE2L2 young donor-
derived HAECs. Cells were transduced with Tandem GFP-RFP LC3B sensor. (A) Representative images of 4 experiments. Scale bar 10 μm. (B) Quantitative analysis.
Three-way ANOVA + Tukey's post-hoc test, n = 4, ***p < 0.001. (C) Immunofluorescent staining of Atg3, Atg5, Atg7, Atg12 and Atg16L in starved siMock and
siNFE2L2 young donor-derived HAECs. Representative images of 3–5 experiments. Scale bar 20 μm. (D) Assessment of Atg12 and p62 level in starved siMock and
siNFE2L2 young donor-derived HAECs. Whole-cell lysates were analysed by immunoblotting. α-tubulin served as a loading control. A representative example of 3
experiments. S – starvation.
A. Kopacz, et al. Redox Biology 34 (2020) 101572
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transcriptional level [39,40]. Though, we believe that this mechanism
is essential in oxidative stress-induced autophagy. Based on the results
presented in our manuscript, we postulate that in prematurely senes-
cent and physiologically ageing endothelial cells the shortage of Nrf2
protein resulting in Keap1 overabundance and increased protein S-ni-
trosation, rather than decreased Nrf2 transcriptional activity, is re-
sponsible for the presence of protein aggregates and inhibition of basal
state autophagy. This conclusion is further supported by the lack of
protein aggregates in DN Nrf2 overexpressing HAECs and Keap1-de-
pleted siNFE2L2 cells. Silencing of Keap1 in Nrf2-deficient cells restored
the level of p62, Atg12 and Atg7. It also rescued functional autophagy.
Also, we observed that rapamycin induced autophagy and aggregate
clearance, despite lack of Nrf2 or its low level in siNFE2L2 young or
aged donor-derived cells, respectively.
In this study, we give new insights into the regulation of Nrf2/
Keap1 axis in ageing, emphasising the significance of the maintenance
of Nrf2:Keap1 balance. We show that Keap1, unrestrained by Nrf2 in
the cytoplasm, is liable for protein aggregation in physiologically and
prematurely ageing ECs. These results have further strengthened the
conviction that Nrf2 serves not only as a transcription factor but also
plays a fundamental role as a repressor of Keap1, as we have outlined in
our recent studies [16,17].
4. Materials and methods
Animals. Nrf2-transcriptional knockout (tKO) C57BL/6 mice, in-
itially developed by Prof. Masayuki Yamamoto as described previously
[51], were kindly provided by Prof. Antonio Cuadrado (Universidad
Autonoma de Madrid) together with WT mice. The mice were crossed
back to C57BL/6J strain every 10 generations in our animal facility. 8-
week old (referred to as young) or 12-14-month-old (aged) male and
female animals were used in the study. Rapamycin was administered at
dose 4 mg/kg i.p. for 14 days, every day; vehicle-treated mice received
5% Tween-80, 5% Kolliphor. All experimental procedures were ap-
proved by the Second Local Ethics Committee for Animal Experiments
in Krakow (No. 133/2018) and followed the guidelines from Directive
2010/63/EU of the European Parliament on the protection of animals
used for scientific purposes.
Cell culture. In the experiments, we used a model of human aortic
endothelial cells (HAECs), which were obtained from donors of dif-
ferent age and sex. The cell lines were provided by PromoCell and
Gibco. The cells were grown in Endothelial Basal Medium (EBM-2)
(Lonza) supplemented with EGM-2MV SingleQuot Kit Supplements &
Growth Factors (Lonza) and 10% foetal bovine serum (FBS) (EURx).
Cells were cultured at 37 °C in a humidified incubator in 5% CO2 at-
mosphere. Upon reaching ~80–90% confluence, the cells were pas-
saged using 0.25% trypsin-0.05% EDTA (1x) phenol red solution
(Gibco). The cells used in all experiments were between passages 5 and
8. To exclude the impact of cell culture on cellular phenotype, when
assessing the impact of donor age, the cells were not kept in culture for
more than 2 passages. Senescence of cells was routinely checked by SA-
β-gal staining.
Transfection with siRNA. 24 h before transfection, 1.5x104 cells
per well were seeded onto 24-well plate. Transfections of HAECs were
performed using 50 nM siRNA targeted against human NFE2L2 (Life
Technologies, s9493), KEAP1 (Life Technologies, s18983), ATG7 (Life
Technologies, s20652) or scrambled siRNA (Life Technologies,
4390846) using Lipofectamine™ 2000 Transfection Reagent (Life
Technologies) in Opti-MEM I Reduced Serum medium (Life
Technologies). The further analysis and treatment of cells were per-
formed at 48 h after transfection.
Transduction of HAECs with adenoviral vectors. The transduc-
tions with adenoviral vectors AdNFE2L2DN or AdGFP were performed at
a multiplicity of infection 50. The transductions with adenoviral vectors
AdKEAP1 or AdGFP were performed at a multiplicity of infection 10 at
24 h after transfection with Mock or NFE2L2-siRNA. The details on DN
Nrf2 are described in our recent paper [17]. After 24 h of incubation,
medium with vectors was removed and fresh EGM-2MV 10% FBS
complete medium was added for the next 24 h.
Quantitative Real-Time PCR. Total RNA was isolated using
RNeasy Mini Kit (Qiagen), according to the manufacturer's description.
The RNA was eluted with 30 μL of nuclease-free water. Reverse tran-
scription reaction was performed using High-Capacity cDNA Reverse
Transcription Kit (Thermo Fisher Scientific, USA) according to the
vendor's protocol. Quantitative RT-PCR was carried out in a
StepOnePlus real-time PCR system (Applied Biosystems) in a mixture
containing SYBR Green PCR Master Mix (Sigma), specific primers and
30 ng of cDNA in a total volume of 15 μL. Primers were designed using
the NCBI primer design tool “Primer-BLAST” or purchased from Sigma.
The EEF2 housekeeping gene was used as a reference. Quantitative
analysis of gene expression was carried out using the ΔΔCt protocol.
Primer sequences: EEF2 F: TGAGCACACTGGCATAGAGGC, R: GACAT
CACCAAGGGTGTGCAG; NFE2L2 F: TTGAGCAAGTTTGGGAGGAGCTA,
R: GGAGAGGATGCTGCTGAAGG; ATG7 F: TGTGCCTCACCAGGTTC
TTG, R: CTGCTCATAAGGGCAGGGAG.
Western blotting. Total protein was isolated using RIPA buffer
(50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% Na-deox-
ycholate, 0.1% SDS) with protease inhibitors (Roche). Western blotting
was performed according to standard procedures. Protein concentration
was determined by BCA method (bicinchoninic acid method). 30 μg of
protein was denatured, and SDS-PAGE was performed, followed by the
wet electrotransfer. The membranes were blocked in 5% non-fat milk
for 1 h and incubated overnight with primary antibodies at 4 °C. Then
they were washed with TBS containing 0.1% Tween and incubated for
1 h with HRP-linked secondary antibodies (Cell Signalling Technology).
The visualisation was performed using Millipore Western Substrate
using X-ray films. Membranes were probed with antibodies against
Keap1 (Clone 144, Millipore), Nrf2 (H-300, Santa Cruz Biotechnology),
p21 (Cell Signaling Technology), p53 (Cell Signaling Technology),
LC3B (Cell Signaling Technology), p62 (Cell Signaling Technology),
Atg12 (Cell Signaling Technology) and a-tubulin (Sigma).
Immunofluorescent stainings. For immunofluorescent stainings,
cells were seeded on coverslips. After treatment, they were fixed with
80% methanol for 10 min in -20 °C. Then, the slides were washed with
Fig. 5. Rapamycin reverses the senescent phenotype of Nrf2-deficient Ecs through the induction of autophagy and protein aggregate clearance. (A–B)
Monitoring of formation of autolysosomes in siMock and siNFE2L2 young donor-derived HAECs treated with 10 nM rapamycin for 24 h. DMSO was used as solvent
control. Cells were transduced with Tandem GFP-RFP LC3B sensor. (A) Representative images of 4 experiments. Scale bar 10 μm. (B) Quantitative analysis. Three-
way ANOVA+ Tukey's post-hoc test, n = 4, *p < 0.05, **p < 0.01. (C–D) Analysis of the level of protein aggregates in siMock and siNFE2L2 young donor-derived
HAECs treated with 10 nM rapamycin for 24 h. DMSO was used as solvent control. Protein aggregates were detected using a fluorescent probe. (C) Representative
images of 4 experiments. Scale bar 10 μm. (D) Quantitative analysis of protein aggregates by flow cytometry. Two-way ANOVA + Tukey's post-hoc test, n = 4,
***p < 0.001. (E) Assessment of SA-β-gal activity in siMock and siNFE2L2 young donor-derived HAECs treated with 10 nM rapamycin for 24 h. DMSO was used as
solvent control. Two-way ANOVA+ Tukey's post-hoc test, n = 5, ***p < 0.001. (F) Comparison of p53 and p21 level in siMock and siNFE2L2 young donor-derived
HAECs treated with 10 nM rapamycin for 24 h. DMSO was used as solvent control. Whole-cell lysates were analysed by immunoblotting. α-tubulin served as a loading
control. A representative example of 3 independent experiments. (G) Assessment of PCNA, proliferating cell nuclear antigen, level in siMock and siNFE2L2 young
donor-derived HAECs treated with 10 nM rapamycin for 24 h. DMSO was used as solvent control. Quantitative data. Two-way ANOVA + Tukey's post-hoc test,
n = 3, ***p < 0.001. (H) Assessment of PCNA, proliferating cell nuclear antigen, level in siMock, siNFE2L2 and siATG7-transfected young donor-derived HAECs
treated with 10 nM rapamycin for 24 h. DMSO was used as solvent control. Quantitative data. Three-way ANOVA + Tukey's post-hoc test, n = 4, ***p < 0.001.
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Fig. 6. Effect of rapamycin on protein aggregation and proliferation capacity in aged cells. (A–B) Assessment of level of protein aggregates in HAECs isolated
from the aged donor and treated with 10 nM rapamycin for 24 h. Protein aggregates were detected using a fluorescent probe. (A) Representative images of 4
experiments. Scale bar 10 μm. (B) Quantitative analysis. Corrected total cell fluorescence (CTCF). Student's t-test, ***p < 0.001. (C) Assessment of PCNA, pro-
liferating cell nuclear antigen, level in HAECs isolated from the aged donor and treated with 10 nM rapamycin for 24 h. DMSO was used as solvent control. Student's
t-test, n = 4, ***p < 0.001. (D–E) En face assessment of the level of protein aggregates in the abdominal aorta of young and aged WT and Nrf2 tKO mice. Protein
aggregates were detected using a fluorescent probe. (D) Scoring of protein aggregation. Two-way ANOVA + Tukey's post-hoc test, n = 6, ***p < 0.001. (E)
Representative images of 6 animals. Scale bar 10 μm.
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PBS 3 times and the cells were blocked with 3% BSA at room tem-
perature. The cells were overnight incubated with primary antibodies
recognising Atg3, Atg5, Atg7, Atg12, Atg16L (Cell Signaling
Technology) or Keap1 (Clone 144, Millipore). The next day, slides were
washed, incubated with Alexa Fluor-conjugated secondary antibody
(Life Technologies), counterstained with DAPI (Sigma Aldrich) and
mounted in Dako Mounting Medium (Dako). High-resolution images
were taken using a meta laser scanning confocal microscope (LSM-880;
Carl Zeiss).
Assessment of cell proliferation. Cells were washed with PBS,
fixed with 4% paraformaldehyde for 8 min, incubated in 99% EtOH for
2 min, washed with PBS, and permeabilised in 0.2% Triton X-100 in
PBS for 20 min. After blocking in 10% goat serum in PBS for 1 h, cells
were incubated with anti-PCNA antibody (Dako; 1:200) diluted in 1%
goat serum at 4 °C overnight. Next, the secondary antibody conjugated
with Alexa Fluor 568 (1:500) was added for 2 h and cells were in-
cubated with Hoechst 33342 for 5 min to stain the nuclei. High-re-
solution images were taken using a meta laser scanning confocal
(caption on next page)
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microscope (LSM-880; Carl Zeiss).
Detection of SA-β-gal activity. Cells were fixed for 3 min with 4%
formaldehyde, washed twice with PBS and incubated overnight with
staining solution (5 mM potassium ferricyanide, 5 mM potassium fer-
rocyanide, 150 mM NaCl, 2 mM MgCl2, 1 mg/mL X-gal in citrate buffer
pH 6). Next day, cells were washed with PBS and stained with Hoechst
33342 to detect nuclei. Images were taken in the brightfield and
fluorescence using a fluorescent microscope (Nikon).
Detection of protein aggregates. Protein aggregates were detected
with the use of fluorescent dye Proteostat™ (Enzo). For immuno-
fluorescent stainings, the cells were seeded on coverslips. After treat-
ment, they were fixed with 80% methanol for 10 min in -20 °C. Then,
the slides were washed with PBS 3 times and the cells were blocked
with 3% BSA at room temperature. The cells were stained with the dye
(dilution 1:2000) overnight at 4 °C and counterstained with DAPI
(Sigma Aldrich) and phalloidin (Cytoskeleton) to visualise nucleus and
Fig. 7. Age- and senescence-related protein aggregation depends on Keap1. (A) Colocalisation of Keap1 and protein aggregates in siMock and siNFE2L2 young
donor-derived HAECs. Immunofluorescent staining. Green – Keap1, red – protein aggregates, blue – nuclei. Representative images of 5 experiments. Scale bar 10 μm.
(B) Functional classification of proteins aggregating differentially in siNFE2L2 comparing to siMock young donor-derived HAECs. An aggregating fraction of proteins
was analysed by mass spectrometry. (C) Comparison of Nrf2 and Keap1 protein level in siMock, siNFE2L2 and siNFE2L2/KEAP1 young donor-derived HAECs. Whole-
cell lysates were analysed by immunoblotting. α-tubulin served as a loading control. A representative example of 4 experiments. (D) Analysis of the level of protein
aggregates in siMock, siNFE2L2 and siNFE2L2+siKEAP1 young donor-derived HAECs. Protein aggregates were detected using a fluorescent probe. Representative
images of 5 experiments. Scale bar 5 μm. (E) Comparison of Keap1, p62 and LC3B level in siMock and siNFE2L2 young donor-derived HAECs treated with 10 nM
rapamycin for 24 h. DMSO was used as solvent control. Whole-cell lysates were analysed by immunoblotting. α-tubulin served as a loading control. A representative
example of 4 experiments. (F) Comparison of Keap1 and Nrf2 level in HAECs isolated from young and aged donor. Age and sex of donors are pointed out. Whole-cell
lysates were analysed by immunoblotting. α-tubulin served as a loading control. A representative example of 3 experiments. (G) Assessment of Keap1 and protein
aggregate level in aged donor-derived HAECs transfected with siMock or siKEAP1. Immunofluorescent staining. Green – Keap1, red – protein aggregates, blue –
nuclei. Representative images of 4 experiments. Scale bar 10 μm. (H) Assessment of PCNA, proliferating cell nuclear antigen, level in siMock and siKEAP1 aged
donor-derived HAECs. Student's t-test, n = 4, ***p < 0.001. (I) Effect of KEAP1 knockdown on SDF-1- and VEGF-induced angiogenic response in aged donor-
derived HAECs – 3D fibrin bead assay. Cells were seeded on beads, immersed in fibrin gel and treated with PBS, SDF-1 or VEGF for 3 days. Two-way
ANOVA + Tukey's post-hoc test, n = 4, ***p < 0.001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version
of this article.)
Table 1
Proteins aggregating in siNFE2L2 young donor-derived HAECs. Whole-cell lysates were analysed by mass spectrometry. For each amino acid. the percentage
higher or equal to that seen in IDPs [23] has been bolded.
Annotation Protein FC siNFE2L2/
siMock
ETGE-like DLG % P % E % S % Q % K
KRT2 Keratin, type II cytoskeletal 2 epidermal 13,87438 – 1.3 6.3 13.1 4.9 5.5
KRT1 Keratin, type II cytoskeletal 1 9,102523 – 1.1 5.7 14.0 5.6 4.3
IKBIP Inhibitor of nuclear factor kappa-B kinase-interacting protein 7,788155 ETNE, EKVE 2.0 7.7 10.0 5.1 11.1
KRT10 Keratin, type I cytoskeletal 10 6,788999 EITE 0.5 7.5 15.1 4.5 3.9
RPL8 60S ribosomal protein L8 5,896294 – 5.4 3.9 3.1 1.9 10.1
RPL13A 60S ribosomal protein L13a 5,525886 – 4.4 4.4 1.5 3.0 13.8
COX5A Cytochrome c oxidase subunit 5A, mitochondrial 3,777531 ETDE 6.7 7.3 4.0 2.0 4.7
DDX5 Probable ATP-dependent RNA helicase DDX5 3,344207 EKDE 5.0 5.7 5.4 4.9 5.5
KRT9 Keratin, type I cytoskeletal 9 3,225101 EDFE 0.5 6.7 14.0 5.3 4.2
EIF2S1 Eukaryotic translation initiation factor 2 subunit 1 3,143379 EQLE, ESME, EKIE 3.2 12.1 5.4 2.2 6.7
RPS3A 40S ribosomal protein S3a 3,080348 – 2.7 5.7 4.2 4.5 14.4
RPS4X 40S ribosomal protein S4, X isoform 2,934382 – 5.3 3.4 3.0 1.1 10.3
RPL7 60S ribosomal protein L7 2,869711 EGVE 3.6 6.9 2.4 2.0 13.7
RPL26 60S ribosomal protein L26 2,52743 ETIE 3.4 6.9 6.2 5.5 16.6
GLIPR2 Golgi-associated plant pathogenesis-related protein 1 2,509817 – 4.5 7.1 10.4 5.2 9.7
RPS20 40S ribosomal protein S20 2,230851 – 5.9 13.4 5.9 1.7 10.9
RPS9 40S ribosomal protein S9 2,17632 – 3.6 6.7 3.6 3.6 9.8
FARSA Phenylalanine–tRNA ligase alpha subunit 2,158905 EGEE, ERSE 5.5 8.7 7.3 4.7 5.5
RPS27A Ubiquitin-40S ribosomal protein S27a 2,114257 – 3.8 6.4 4.5 3.8 16.0
NT5E 5-nucleotidase 2,05089 EFDE 4.7 5.1 6.6 3.0 6.1
FN1 Fibronectin; Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3 1,849641 EDGE, EGDE, EAEE 7.8 5.9 8.1 5.3 3.1
RPL18 60S ribosomal protein L18 1,807441 – 7.4 2.7 4.3 2.7 13.8
EEF1G Elongation factor 1-gamma 1,774063 EMDE, EKRE 5.9 9.2 5.7 5.0 7.3
RPL31 60S ribosomal protein L31 1.764461 – 4.8 6.4 2.4 0.8 12.8
PTRF Polymerase I and transcript release factor 1.734553 EITE. EAVE. EVNE. EAPE. EGEE.
EVEE
3.8 14.4 7.4 3.3 10.0
PPIB Peptidyl-prolyl cis-trans isomerase B 1.693058 EGME 3.7 5.6 4.2 0.9 12.0
RPS14 40S ribosomal protein S14 1.666266 – 4.6 6.0 6.0 3.3 7.9
LMNA Prelamin-A/C; Lamin-A/C 1.609112 EDDE. EGEE 2.3 10.7 10.4 6.0 6.0
H3F3 Histone H3 1.578381 EASE 4.4 5.1 4.4 5.9 9.6
RPL6 60S ribosomal protein L6 1.572808 EITE 6.3 5.2 4.9 3.1 18.1
ANPEP Aminopeptidase N 1.529331 EFEGE. EPTE. ENKE. ELVE. ECEE 4.8 6.3 8.1 4.1 4.7
RPS13 40S ribosomal protein S13 1.483448 – 5.3 3.3 7.3 2.6 11.9
DDOST Dolichyl-diphosphooligosaccharide–protein glycosyltransferase 48 kDa
subunit
1.435433 DLG. EFDE 5.3 4.6 9.4 3.1 4.6
DAD1 Dolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit
DAD1
1.416131 – 3.5 2.7 10.6 4.4 1.8
EHD1 EH domain-containing protein 1 1.390275 EAEE. EFSE 6.0 7.5 4.9 3.7 8.2
SLC25A3 Phosphate carrier protein. mitochondrial 1.33242 EMPE 6.6 4.7 6.6 3.3 6.9
HSPA6 Heat shock 70 kDa protein 6 1.328892 EEVE. EEYE. DLG 3.9 8.1 5.3 4.7 6.1
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Fig. 8. Protein aggregation is dependent on Keap1-
driven S-nitrosation. (A) Colocalisation of protein ag-
gregates and S-nitrosated proteins in siMock and siNFE2L2
young donor-derived HAECs. Immunofluorescent staining.
Green – S-nitrosated proteins, red – protein aggregates,
blue – nuclei. Representative images of 3 experiments.
Scale bar 5 μm. (B) Colocalisation of Keap1 and protein
aggregates in siMock and siNFE2L2 young donor-derived
HAECs incubated with 1 mM sodium ascorbate (SA) for
24 h to reduce S-nitrosated cysteines. Immunofluorescent
staining. Green – Keap1, red – protein aggregates, blue –
nuclei. Representative images of 3 experiments. Scale bar
5 μm. (C) Colocalisation of Keap1 and protein aggregates in
aged donor-derived HAECs incubated with 1 mM sodium
ascorbate (SA) for 24 h to reduce S-nitrosated cysteines.
Immunofluorescent staining. Green – Keap1, red – protein
aggregates, blue – nuclei. Representative images of 4 ex-
periments. Scale bar 10 μm. (For interpretation of the re-
ferences to colour in this figure legend, the reader is re-
ferred to the Web version of this article.)
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actin, respectively. The next day, slides were washed and mounted in
Dako Mounting Medium (Dako). High-resolution images were taken
using a meta laser scanning confocal microscope (LSM-880; Carl Zeiss).
For quantitative analysis with flow cytometry, the cells were de-
tached with trypsin, washed with PBS, permeabilised with ice-cold
methanol for 10 min and stained for 30 min with the Proteostat™ Dye.
Before collection on the flow cytometer, the cells were washed with
PBS. The cells were collected in PE-Texas Red channel using BD
Fortessa flow cytometer.
En face staining of protein aggregates. For en face im-
munostaining, the mice were perfused with 1% PFA. The whole aorta
was removed, gently cleaned of perivascular fat and fixed for 15 min
with 4% paraformaldehyde (PFA). Next, aortas were incubated for 3 h
in blocking permeabilising buffer (0.3% Triton X-100, 5% goat serum,
1% BSA) and then incubated overnight with the Proteostat™ Dye
(Enzo). After that, the aortas were washed, and the nuclei were coun-
terstained with DAPI (Sigma-Aldrich). After washing, the aortas were
opened, intima facing up and mounted with Dako Fluorescence
Mounting Medium (Dako). High-resolution images were taken using a
meta laser scanning confocal microscope (LSM-880; Carl Zeiss). The
assessment of protein aggregation was performed via macroscopic
scoring: 1 – no aggregates; 2 – aggregates visible in up to 20% of the
cellular surface (mostly around ER), 3 – aggregates up to 40%; 4 – up to
60%; 5 – up to 90%.
Life cell imaging. At 24 h after transfection, cells were transduced
with Premo™ Autophagy Tandem Sensor RFP-GFP-LC3B according to
manufacturer's recommendations. The cells were analysed at 48 h after
transduction under a meta laser scanning confocal microscope (LSM-
880; Carl Zeiss).
Atomic force microscopy. Measurements were conducted using
the Nanowizard 3 AFM instrument (JPK Instruments). Round glass
coverslips with cells were placed in a liquid cell (BioCell, JPK
Instruments) and analysed at 37 °C. For live-cell measurements, Hank's
balanced Salt Solution (Gibco) was used. For time‐dependent AFM
measurements, a group of two to five cells was selected and in-
vestigated for 1–3 h. Each experiment was repeated at least three times,
and a single representative experimental data set was presented. AFM
data were performed using in force versus distance (FD)–based imaging
mode (QI; JPK Instruments) allowing for high-resolution imaging of
living cells in a time-dependent manner. The methodology enabling
tracking the dynamic changes in cellular structures was described in
detail before [52,53]. Briefly, single FD-curve is performed in every
pixel point of the image and then translated into images of topography
and stiffness. Topographical images were translated from the selected
trigger force. A linear fit to the selected part of the FD curve (usually
corresponding to 100 nm of maximum indentation) was used to cal-
culate stiffness [52]. Experiments were performed using commercially
available cantilevers of a radius of 25 nm on cantilevers with a spring
constant of 0.1 N/m (SCM-PIC-V2; Bruker). The loading force used
varied from 1 to 3.5 nN and was adjusted to obtain a clear contrast of
cytoskeletal filaments. The captured images of topography and stiffness
were analysed using JPK Data Processing Software. Raw AFM images
were subject to minimum processing (plane fitting, contrast correc-
tions) by employing the JPK Processing Software.
Mass spectrometry analysis. Proteome profiling of soluble frac-
tion of siMock and siNFE2L2 cells was described in our previous paper
[16]. For the mass spectrometry analysis of protein aggregates, protein
was collected using 50 mM Tris (pH 8.0), 0.5% Triton X-100, 150 mM
NaCl, 1 mM EDTA, 10% glycerol. After 15 min, the samples were
centrifuged at 14 000g for 30 min in 4 °C. The supernatant was con-
sidered a soluble fraction, and the remaining pellet was dissolved in 1%
SDS buffer and further centrifuged. After this step, the supernatant was
regarded as consisting of proteins form an aggregated fraction. The
proteins were precipitated with chloroform/methanol. Precipitated
proteins after sonication in BioRuptor (30/30 s, setting: high) were
processed as described previously [16].
Detection of S-nitrosation by biotin switch assay. The procedure
was performed as described in our previous paper. For immuno-
fluorescence detection of S-nitrosation proteins, streptavidin con-
jugated to Alexa Fluor 488 (Life Technologies) was used. The protein
aggregates were detected using Proteostat ™ Dye (Enzo). High-resolu-
tion images were taken using a meta laser scanning confocal micro-
scope (LSM-880; Carl Zeiss).
Treatment of cells. HAECs were incubated for 24 h with 10 nM
rapamycin (Sigma) or 1 mM sodium ascorbate (SA) (Sigma) in EGM-
2MV medium containing 10% FBS. To induce starvation, the cells were
incubated with Earl's Balanced Salt Solution (EBSS) for 3 h.
Statistical analysis. All experiments were performed in duplicates
and were repeated at least three times. Data are presented as
mean ± SEM. Statistical assessment was done with t-test or Mann-
Whitney U test for two-group comparisons or by analysis of variance
(ANOVA), followed by a Tukey posthoc test for multiple comparisons.
Mann-Whitney test was used for the analysis of mass spectrometry data.
Differences were accepted as statistically significant for p < 0.05.
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AFM atomic force microscopy
Atg autophagy-related protein
ECs endothelial cells
HAEC human aortic endothelial cells
IDP intrinsically disordered protein
Keap1 Kelch-like ECH-associated protein 1
mTOR mammalian target of rapamycin
Nrf2 nuclear factor erythroid 2-related factor 2
PBS phosphate-buffered saline
PCNA proliferating cell nuclear antigen
PFA paraformaldehyde
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SA sodium ascorbate
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